A Study of Firsekibart Versus Anakinra in Adult-Onset Still's Disease

Efficacy and Safety Study of ACZ885 in Patients With Active Recurrent or Chronic TNF-receptor Associated Periodic Syndrome (TRAPS).

NCT01242813 ·Status: COMPLETED ·Phase: PHASE2

Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)

NCT02592798 ·Status: COMPLETED ·Phase: PHASE2

Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis

NCT02169219 ·Status: COMPLETED ·Phase: PHASE4

To Compare the Efficacy and Safety of FK506 vs IVC in the Treatment of Class III-IV LN

NCT00302549 ·Status: COMPLETED ·Phase: NA

Rituximab for Idiopathic Nephrotic Syndrome

NCT04494438 ·Status: COMPLETED ·Phase: PHASE3

RItuximab From the FIRst Episode of Idiopathic Nephrotic Syndrome

NCT03970577 ·Status: UNKNOWN ·Phase: PHASE2

A Study to Evaluate Setanaxib in Patients With Alport Syndrome

NCT06274489 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Comparison of Tofacitinib and Methotrexate in Takayasu's Arteritis

NCT05102448 ·Status: RECRUITING ·Phase: PHASE4

Effect of Tofacitinib in Treating ANCA-associated Vasculitis

NCT04973033 ·Status: COMPLETED ·Phase: NA

Luspatercept for Clonal Cytopenias of Uncertain Significance

NCT06788691 ·Status: RECRUITING ·Phase: PHASE2

Lymphocyte Markers As Predictors Of Responsiveness To Rituximab Among Patients With Idiopathic Nephrotic Syndrome

NCT03501459 ·Status: RECRUITING ·Phase: PHASE3

Mycophenolate Mofetil in Membranous Nephropathy and Focal Segmental

NCT00404833 ·Status: COMPLETED ·Phase: PHASE3

A Study of Telitacicept in Patients With Ocular Myasthenia Gravis (OMG)

NCT07249632 ·Status: RECRUITING ·Phase: PHASE3

Myfortic® for Minimal Change Nephrotic Syndrome (MCNS): a Randomized Study

NCT01185197 ·Status: COMPLETED ·Phase: PHASE4

Evaluation of Low Dose Corticosteroids Efficiency, Associated With Myfortic ® in the Treatment of Nephrotic Syndrome

NCT01197040 ·Status: COMPLETED ·Phase: PHASE3

Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN

NCT05755386 ·Status: RECRUITING ·Phase: PHASE3

Phase 2 Study of Human Umbilical Cord Derived Mesenchymal Stem Cell for the Treatment of Lupus Nephritis

NCT01539902 ·Status: UNKNOWN ·Phase: PHASE2

Safe Effective Therapy With Low-Dose Glucocorticoid in ANCA-Associated Vasculitis (SAFE-LOW)

NCT06983821 ·Status: RECRUITING ·Phase: PHASE3

Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome

NCT05926505 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Assessment of Netosis During COVID-19, Under Treatment With Anakinra, an Interleukin-1 Receptor Antagonist

NCT04594356 ·Status: COMPLETED

Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis

NCT07160608 ·Status: RECRUITING ·Phase: PHASE2

Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil in Children With Steroid-dependent Nephrotic Syndrome

NCT05843968 ·Status: RECRUITING ·Phase: PHASE2

Clinical Study of Anti-tumor Necrosis Factor Therapy in Patients With Takayasu Arteritis

NCT02457585 ·Status: UNKNOWN ·Phase: PHASE2

MOR202 for Refractory MN

NCT04893096 ·Status: COMPLETED ·Phase: PHASE2

Avacopan vs Reduced-dose Glucocorticoids in ANCA-associated Vasculitis

NCT06611696 ·Status: RECRUITING ·Phase: PHASE4